High Protein, Low Calorie Diet Helps Obese Surgical Patients

November 24, 1997

COLUMBUS, Ohio -- A study at Ohio State University has shown that a high-protein, low-calorie diet may help obese hospital patients control their blood sugar levels.

The study, which appeared in a recent issue of the American Journal of Clinical Nutrition, showed that the new diet allows obese patients to burn body fat for energy without endangering their health -- and maintain a stable blood sugar level, which helps them avoid diabetes and hyperglycemia.

These two conditions have been shown to slow healing and increase the chance of acquiring post-operative infections.

“Until now, there hasn’t been a good strategy for providing nutrition to obese patients, even though they make up as much as one third of the typical patient population,” said Patricia Choban, assistant professor of surgery and lead author of the study. “Some doctors just let them live off their body fat, but then the patients lose muscle instead, and we wanted to avoid that. We also didn’t want to overfeed them, because their high blood sugar levels would slow wound healing. So we came up with a low-calorie diet that helped them burn fat for energy but maintained their protein levels, and it seemed to work.”

At issue in the study was not how to help patients lose weight, but rather how to best provide them with good nutrition while in the hospital.

Thirty obese surgical patients at Ohio State University Hospitals participated in the study, including 10 patients with diabetes. The patients weighed an average 63 percent above their ideal body weight.

The patients were all to undergo surgery for conditions such as cancer, pancreatic disease, internal hemorrhage, and trauma. Two patients died during the course of the study, one of adult respiratory distress syndrome and the other of cardiac arrest, both unrelated to the hospital diet.

The researchers divided the patients into two groups, with 16 patients on the experimental low-fat, low-sugar, high-protein diet, and the other 14 on a standard hospital diet. Each group contained five diabetic patients.

The researchers tested the nutritional health of the patients by measuring the amount of nitrogen in their urine. According to those tests, the patients on the experimental diet were just as nutritionally balanced as the patients on the regular diet. Choban said that these results supported the idea that obese patients can be placed on a diet that will lower their risk of blood-sugar-related conditions, without compromising their overall health.

Because the five diabetic patients on the new diet consumed much less sugar, they required smaller doses of insulin to maintain healthy blood sugar levels, and also required the drug for fewer days during their hospital stay.

Choban pointed to previous research in which patients with lower blood sugar levels heal faster and lessen their risk of postoperative infection. She cited this possibility as an advantage of the high-protein, low-calorie diet.

Choban added that the diet would most benefit patients with type II diabetes -- the kind of diabetes most common in adults -- in which the person produces plenty of insulin, but his or her cells don’t respond to it as much as they should. Choban said that when type II diabetics get sick, their cells respond even less to insulin, and sugary diets intensify the effect.

The patients in this study received their food intravenously, but Choban said that the same diet would benefit patients who are fed through a stomach tube or who are healthy enough to eat normally. The regimen requires only that a patient possess normal liver and kidney function, so they can process the high-protein portion of the diet.

Choban said that hospitals may adopt this technique immediately. Physicians only have to pick a mixture of protein, fat, and sugar, and dose it at a rate based on the patients’ deviation from their ideal body weight. The technique doesn’t require any special technology -- only the inexpensive equipment for testing nitrogen excretion in patients’ urine that is already available at most hospitals.

“Obese patients are not just cared for at large university hospitals, but also at tiny fifty-bed hospitals in rural areas. It’s important that anyone can apply this method at any hospital equally safely,” said Choban. Choban and her colleagues are now examining the medical records of all the patients who needed nutritional support from the hospital during the last two years, to see how long they stayed on their diet, and whether or not they experienced any complications. Choban said the results will help the researchers double-check the safety and efficacy of the high-protein, low-calorie diet plan.
-end-


Ohio State University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.